ACCESS Newswire
ACCESS Newswire
More ACCESS Newswire
View Older Stories View Newer Stories-
WidePoint Awarded $3.2 Million Mobility Managed Services Contract from the Federal Communications Commission
-
Tech for Good: Cadence Employees Volunteer in India
-
Limitless Funding Empower Traders with Access to Vast Capital Unveiling Its Proprietary Trading Program
-
Grovara Partners With TransferMate To Vastly Lower Costs and Increase Speed of Cross-Border Payments on First B2B Online Marketplace For Export/Import
-
The Now Corporation (OTC: NWPN) Ignites the African Gold Industry with a Game-Changing Acquisition
-
Paradigm B2B Announces Release of Fifth Annual Evaluation of Digital Commerce Solutions for B2B
-
Yunhong CTI Ltd. to Host Second Quarter 2023 Conference Call on August 3rd
-
LabWare Selected as Honoree of 2023 Drexel LeBow Analytics 50 Award
-
ISSA, LLC Selected as an Arizona Top Workplace for 2023
-
Tom Ferry's Success Summit Provides 'The Path Forward' in Today's Challenging Real Estate Market
-
Issuer Direct Announces Sponsorship of the Second-Annual Marge "Madness" Breast Cancer Fundraiser Golf Tournament
-
Centamin PLC Announces New Egyptian Mining Regulatory Framework Agreed
-
Wearable Health Solutions (WHSI) Files NPI to Enhance Health Information Exchange
-
Grid Dynamics Earns Membership in Microsoft’s Azure Migration and Modernization Program - Enabling Its Clients to Accelerate Time to Value on Cloud Transformation Initiatives and Invest in More Adva
-
Celebrating 10 Years of Purpose-led Fashion Design
-
The Winners of the 2023 New Voices $150,000 POWER PITCH Sponsored by Entergy Are Announced
-
Electrovaya Launches Infinity-HV Battery Systems for Electric Bus, Truck and Energy Storage Applications
-
Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
-
Inovatec to Demonstrate Market-Leading Cloud Lending Solutions at the World Credit Union Conference July 23 - 26
-
Former Microsoft Global AI Leader and Head of Global Sales Khadija Mustafa Joins SKYX as Senior Tech, AI, and Global Business Advisor
-
GameSquare's Stream Hatchet Reports Esports Livestreaming Hours Increased 15% During the 2023 First Quarter
-
Halberd Corporation 2Q23 CEO Letter
-
GGL Sells Lithium Project, Nevada
-
New Research From the Health Equity Collaborative: Healthcare Reform Proposals to Support Diverse Communities
-
CAT Strategic Successfully Restructures Loan Agreement to Facilitate Gold Jackpot Project Financing and South Preston Spin-Off
-
Avinger to Announce Second Quarter 2023 Results on July 27
-
Siyata Mobile Inc. Announces Participation at APCO 2023
-
Planting Hope Announces Financial Transactions Resulting in a Combined US$2.45M (C$3.27M) Benefit to the Company
-
Stillwater Critical Minerals Launches Expansion Drill Program
-
ARway.ai Secures $500,000 Annual License Agreement for Its Augmented Reality Spatial Computing Navigation Platform
-
Focus Financial Partners to Release 2023 Second Quarter Results on August 3
-
Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential
-
Eagle Plains Provides Update on Expanded Vulcan Drill Program, Announces Flow-through Financing
-
Multinational Industry Leader Adopts OneSoft's CIM Solution
-
Galway Metals Intersects 8.4g/t Au over 5.7m, and 1.7 g/t Au over 13.6m plus 19.0 Au over 3.0m at the South Deposit at Clarence Stream; Drilling at SW Deposit
-
WGA Announces Passing of Richard James Whalen
-
FTSE4Good Index Includes Linde for Eighth Consecutive Year
-
Long Form Documentation Now Finalised and Executed for Mabilo Restructure
-
Avidbank Holdings, Inc. Announces Net Income of $4.7 Million for the Second Quarter of 2023
-
Atlas Travel & Technology Group Publishes 2022 Corporate Social Responsibility Report
-
Nano One Advances its Commercial LFP Plans at Québec Facility, Secures Six New Patents
-
Bradda Head Lithium Ltd Announces London South East Investor Webinar Presentation
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19
-
Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19


